### 32729 Federal Register / Vol. 79, No. 109 / Friday, June 6, 2014 / Notices

provisions has its own criteria and process that must be followed; no exceptions are automatic.

Prior essential use applications were typically for chlorofluorocarbons (CFCs) for metered dose inhalers (MDIs). The Parties last authorized an essential use exemption for the United States allowing the production of CFCs for MDIs in 2008 for the 2010 calendar year.Effective December 31, 2013, all CFCcontaining MDIs have been removed from the Food and Drug Administration’s (FDA’s) list of essential uses found at 21 CFR 2.125(e). The United States has not nominated halons for aviation safety as an essential use. If EPA were to receive an application for halons for aviation safety, EPA would work with other relevant Federal agencies to establish the process for reviewing applications for this use.

II. Essential Use Nomination Process

Entities requesting essential use exemptions should send a completed application to EPA on the candidate use by September 30, three years prior to the year of the intended use. Upon receipt of applications, EPA will review the information and work with other interested Federal agencies as required in section 604 of the Clean Air Act to determine whether the candidate use satisfies Clean Air Act requirements, as well as whether it meets the essential use criteria adopted by the Parties to the Montreal Protocol and warrants nomination by the United States for an exemption.

All Parties, including the United States, must transmit nominations to the UNEP Ozone Secretariat by January 31 to be considered by the Parties at their annual meeting at the end of that year. The UNEP Ozone Secretariat forwards nominations to the Montreal Protocol’s Technical and Economic Assessment Panel (TEAP) and its relevant Technical Options Committee (TOC). The TOC and the TEAP review the nomination to determine whether it meets the criteria for an essential use established by Decisions IV/25, XII/2, XV/5, and XVI/ 12, and to make recommendations to the Parties for essential use exemptions. The Parties then consider those recommendations at their annual meeting before making a final decision.

An essential use exemption is granted to the nominating Party for a specific quantity of a specified ODS for a specific time period. If the Parties determine that a specified use of a controlled substance is essential and authorize an exemption from the Protocol’s production and consumption phaseout, EPA may then take domestic action to allow the production and consumption to the extent consistent with the Clean Air Act. III. Information Required for Essential Use Applications

In the past, EPA had annually issued a notice requesting applications for essential use exemptions. Through this action, EPA provides the opportunity to submit applications for essential use exemptions for class I substances for all future control periods (calendar years). Applications requesting essential use allowances should include information that U.S. Government agencies and the Parties to the Protocol can use to evaluate the candidate use according to the criteria in the Decisions described above. Applications that fail to include sufficient information may not be nominated.

Specifically, all applications submitted to EPA should include the information requested in the current version of the TEAP Handbook on Essential Use Nominations, which as of the date of this notice was last updated in 2009. The handbook is available electronically on the internet at http:// ozone.unep.org/teap/Reports/TEAP

_ Reports/EUN-Handbook2009.pdf. EPA requests that applications contain the following information, as described in the handbook, in order for the U.S. to provide sufficient information to the Montreal Protocol’s technical review bodies within the nomination:

1. A detailed description of the use that is the subject of the nomination;

2. Details of the type, quantity, and quality of the controlled substance that is requested to satisfy the use;

3. The period of time and the annual quantities of the controlled substances that are requested;

4. An explanation of why the nominated volumes and the intended use of these quantities are necessary for health and/or safety, or critical for the functioning of society;

5. An explanation of what other alternatives and substitutes are currently available and what steps are being taken to implement those alternatives and substitutes;

6. An explanation of why alternatives and substitutes are not sufficient or appropriate to eliminate the proposed

use;

7. A description of the measures that are proposed to eliminate all unnecessary emissions, including design considerations and maintenance procedures;

8. An explanation of what efforts are being undertaken to employ other measures for this application in the future; 9. A description of the efforts that have been made to acquire stockpiled or recycled controlled substance for this application both domestically and internationally as well as an explanation of what efforts have been made to establish banks for the controlled substance; and

10. A description of any other barriers encountered in attempts to eliminate the use of the controlled substance for this application.

In addition, applicants should specify which exemption in CAA section 604 they are seeking: the exemption for medical devices at section 604(d)(2) or the exemption for aviation safety at section 604(d)(3). Each of these statutory exemptions has its own process and criteria that would need to be satisfied prior to any regulatory action authorizing the exemption.

The Office of Management and Budget (OMB) has approved the information collection requirements contained in this notice under the provisions of the Paperwork Reduction Act, 44 U.S.C.
3501 et seq. and has assigned OMB control number 2060–0170.

Dated: May 30, 2014. Paul Gunning, Acting Director, Office of Atmospheric Programs.
[FR Doc. 2014–13235 Filed 6–5–14; 8:45 am]

**BILLING CODE 6560–50–P**

**ENVIRONMENTAL PROTECTION AGENCY** 

**[ER–FRL–9015–3]**

**Environmental Impact Statements; Notice of Availability** 

Responsible Agency: Office of Federal Activities, General Information (202)
564–7146 or http://www.epa.gov/ compliance/nepa/. Weekly receipt of Environmental Impact

Statements Filed 05/27/2014 Through 05/30/2014 Pursuant to 40 CFR 1506.9.

Notice

Section 309(a) of the Clean Air Act requires that EPA make public its comments on EISs issued by other Federal agencies. EPA’s comment letters on EISs are available at: http:// www.epa.gov/compliance/nepa/ eisdata.html. EIS No. 20140162, Final EIS, FAA, TX

, SpaceX Texas Launch Site, Review Period Ends: 07/07/2014, Contact: Stacey Zee 202–267–9305. EIS No. 20140163, Draft EIS (Tiering),

NASA, FL, Tier 2—Mars 2020 Mission, Comment Period Ends: 07/


### 32730 Federal Register / Vol. 79, No. 109 / Friday, June 6, 2014 / Notices

21/2014, Contact: George Tahu 202–
258–0016. EIS No. 20140164, Final Supplement,

FHWA, NCDOT, NC, Monroe Connector/Bypass, Contact: George Hoops 919–707–6022, Under MAP–21 section 1319, FHWA has issued a single FSEIS and ROD. Therefore, the 30-day wait/review period under NEPA does not apply to this action. EIS No. 20140165, Draft EIS, USACE,

WA , Skagit River Flood Risk Management General Investigation, Comment Period Ends: 07/21/2014, Contact: Hannah Hadley 206–764–
6950. EIS No. 20140166, Draft EIS, USACE,

WA , BP Cherry Point Dock, Comment Period Ends: 08/06/2014, Contact: Olivia Romano 206–764–6960.

Amended Notices EIS No. 20130365, Draft EIS, NMFS,

USFWS, BR, CA , Bay Delta Conservation Plan, Comment Period Ends: 07/29/2014, Contact: Ryan Wulff 916–930–3733.
Revision to the FR Notice Published 02/21/2014; Extending Comment Period from 06/13/2014 to 07/29/2014; The U.S. Department of the Interior’s Bureau of Reclamation and Fish and Wildlife Service, the U.S. Department of Commerce’s National Marine Fisheries Service are joint lead agencies for the above project.

Dated: May 3, 2014. Cliff Rader, Director, NEPA Compliance Division, Office of Federal Activities.
[FR Doc. 2014–13231 Filed 6–5–14; 8:45 am]

**BILLING CODE 6560–50–P**

**ENVIRONMENTAL PROTECTION AGENCY** 

**[EPA–HQ–OPP–2004–0202; FRL–9911–37]**

**Pentachloronitrobenzene (PCNB); Notice of Receipt of Requests To**  **Voluntarily Amend Registrations To Terminate Certain Uses** 

**AGENCY :**  Environmental Protection Agency (EPA).

**ACTION :**  Notice.

**SUMMARY :**  In accordance with the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), EPA is issuing a notice of receipt of requests by the registrant to voluntarily amend PCNB registrations for one manufacturing-use product and two end-use products to terminate or delete a number of uses. The requests would delete the use of Technical Grade PCNB (EPA Registration #5481–197) for formulation into products for use as seed treatments (except for the treatment of cloves of garlic) and products for use on certain non-residential terrestrial non-food crops. The requests also would terminate the use of the PCNB product with EPA Registration #5481–8988 on bedding plants, flowering plants, foliage plants, and bulb crops, and the use of the PCNB product with EPA Registration #5481–8992 on bedding plants, flowering plants, foliage plants, azaleas, camellias, gladiolus (broadcast), and cut flowers. These use deletion requests are detailed in Table 1 in Unit III. The requests would not terminate the last PCNB products registered for use in the United States. EPA intends to grant these requests at the close of the comment period for this announcement unless the Agency receives substantive comments within the comment period that would merit its further review of the requests, or unless the registrant withdraws its request(s). If these requests are granted, any sale, distribution, or use of products listed in this notice will be permitted after the uses are deleted only if such sale, distribution, or use is consistent with the terms as described in the final order.

**DATES :**  Comments must be received on or before July 7, 2014.

**ADDRESSES :**  Submit your comments, identified by docket identification (ID) number EPA–HQ–OPP–2004–0202, by one of the following methods:

• Federal eRulemaking Portal: http:// www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute.

• Mail: OPP Docket, Environmental Protection Agency Docket Center (EPA/ DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001.

• Hand Delivery: To make special arrangements for hand delivery or delivery of boxed information, please follow the instructions at http:// www.epa.gov/dockets/contacts.htm. Additional instructions on commenting or visiting the docket, along with more information about dockets generally, is available at http://www.epa.gov/ dockets.

**FOR FURTHER INFORMATION CONTACT :**  Jill Bloom, Pesticide Re-evaluation Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001; telephone number: (703) 308–8019; fax number: (703) 308– 7070; email address: bloom.jill@epa.gov.

**SUPPLEMENTARY INFORMATION :**  I. General Information A. Does this action apply to me?

This action is directed to the public in general, and may be of interest to a wide range of stakeholders including environmental, human health, and agricultural advocates; the chemical industry; pesticide users; and members of the public interested in the sale, distribution, or use of pesticides. Since others also may be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. B. What should I consider as I prepare my comments for EPA?

1. Submitting CBI. Do not submit this information to EPA through regulations.gov or email. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD–ROM that you mail to EPA, mark the outside of the disk or CD–ROM as CBI and then identify electronically within the disk or CD–ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2.

2. Tips for preparing your comments. When submitting comments, remember
to:

i. Identify the document by docket ID number and other identifying information (subject heading, Federal Register date and page number).

ii. Follow directions. The Agency may ask you to respond to specific questions or organize comments by referencing a Code of Federal Regulations (CFR) part or section number.

iii. Explain why you agree or disagree; suggest alternatives and substitute language for your requested changes.

iv. Describe any assumptions and provide any technical information and/ or data that you used.

v. If you estimate potential costs or burdens, explain how you arrived at your estimate in sufficient detail to allow for it to be reproduced.

vi. Provide specific examples to illustrate your concerns and suggest alternatives.

vii. Explain your views as clearly as possible, avoiding the use of profanity or personal threats.

viii. Make sure to submit your comments by the comment period deadline identified.